Table 2. Surviving fraction at 2Gy, 4Gy, and 6y radiation based on clonogenic survival assays for head and neck squamous cell carcinoma cell lines.
| Cell line | 2Gy (%SF) | S.E.M. | 4Gy (%SF) | S.E.M. | 6Gy (%SF) | S.E.M. |
|---|---|---|---|---|---|---|
| HN30 | 55.1 | ±15.16 | 35.5 | ±23.12 | 20.1 | ±17.47 |
| UMSCC6 | 59.1 | ±15.12 | 11.9 | ±7.80 | 0.8 | ±0.57 |
| PCI15A | 65.2 | ±2.31 | 23.3 | ±5.84 | 9.9 | ±6.36 |
| MDA686LN | 65.3 | ±1.40 | 32.4 | ±11.63 | 16.9 | ±2.10 |
| HN31 | 74.2 | ±6.75 | 38.0 | ±17.89 | 17.3 | ±13.72 |
| HN5 | 83.6 | ±6.62 | 44.0 | ±13.91 | 21.0 | ±6.92 |
| PCI15B | 87.4 | ±2.19 | 50.0 | ±13.91 | 24.5 | ±6.92 |
| DET562 | 89.2 | ±6.53 | 37.4 | ±5.51 | 22.4 | ±7.27 |
Abbreviations: Gy (Gray); SF (surviving fraction); S.E.M. (standard error of the mean).